412 related articles for article (PubMed ID: 26337653)
1. Sarcopenia Evaluated Using the Skeletal Muscle Index Is a Significant Prognostic Factor for Metastatic Urothelial Carcinoma.
Taguchi S; Akamatsu N; Nakagawa T; Gonoi W; Kanatani A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Homma Y
Clin Genitourin Cancer; 2016 Jun; 14(3):237-43. PubMed ID: 26337653
[TBL] [Abstract][Full Text] [Related]
2. Significance of sarcopenia as a prognostic factor for metastatic urothelial carcinoma patients treated with systemic chemotherapy.
Abe H; Takei K; Uematsu T; Tokura Y; Suzuki I; Sakamoto K; Nishihara D; Yamaguchi Y; Mizuno T; Nukui A; Kobayashi M; Kamai T
Int J Clin Oncol; 2018 Apr; 23(2):338-346. PubMed ID: 29098519
[TBL] [Abstract][Full Text] [Related]
3. Skeletal Muscle Mass Reduction Velocity as a Simple Prognostic Indicator for Patients with Metastatic Urothelial Carcinoma Receiving Second-Line Chemotherapy.
Nagai T; Naiki T; Iida K; Nozaki S; Etani T; Sugiyama Y; Ando R; Yanase T; Chaya R; Moritoki Y; Kobayashi D; Akita H; Okamura T; Yasui T
Asian Pac J Cancer Prev; 2019 Oct; 20(10):2995-3000. PubMed ID: 31653146
[TBL] [Abstract][Full Text] [Related]
4. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder.
Miyake M; Morizawa Y; Hori S; Marugami N; Shimada K; Gotoh D; Tatsumi Y; Nakai Y; Inoue T; Anai S; Torimoto K; Aoki K; Tanaka N; Fujimoto K
BMC Cancer; 2017 Mar; 17(1):237. PubMed ID: 28359307
[TBL] [Abstract][Full Text] [Related]
6. Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma.
Fukushima H; Yokoyama M; Nakanishi Y; Tobisu K; Koga F
PLoS One; 2015; 10(1):e0115895. PubMed ID: 25612215
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
[TBL] [Abstract][Full Text] [Related]
8. Posttherapeutic skeletal muscle mass recovery predicts favorable prognosis in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy.
Fukushima H; Kataoka M; Nakanishi Y; Sakamoto K; Takemura K; Suzuki H; Ito M; Tobisu KI; Fujii Y; Koga F
Urol Oncol; 2018 Apr; 36(4):156.e9-156.e16. PubMed ID: 29051030
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality.
Psutka SP; Carrasco A; Schmit GD; Moynagh MR; Boorjian SA; Frank I; Stewart SB; Thapa P; Tarrell RF; Cheville JC; Tollefson MK
Cancer; 2014 Sep; 120(18):2910-8. PubMed ID: 24840856
[TBL] [Abstract][Full Text] [Related]
10. Decrease in skeletal muscle index 1 year after radical cystectomy as a prognostic indicator in patients with urothelial bladder cancer.
Ha YS; Kim SW; Kwon TG; Chung SK; Yoo ES
Int Braz J Urol; 2019; 45(4):686-694. PubMed ID: 30901172
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenia is associated with survival in patients with urothelial carcinoma treated with systemic chemotherapy.
Shimizu R; Honda M; Teraoka S; Yumioka T; Yamaguchi N; Kawamoto B; Iwamoto H; Morizane S; Hikita K; Takenaka A
Int J Clin Oncol; 2022 Jan; 27(1):175-183. PubMed ID: 34606022
[TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis.
Gu DH; Kim MY; Seo YS; Kim SG; Lee HA; Kim TH; Jung YK; Kandemir A; Kim JH; An H; Yim HJ; Yeon JE; Byun KS; Um SH
Clin Mol Hepatol; 2018 Sep; 24(3):319-330. PubMed ID: 29706058
[TBL] [Abstract][Full Text] [Related]
13. Second-Line Chemotherapy for Metastatic Urothelial Carcinoma: Importance of Lymph Node-Only Metastasis as a Prognostic Factor and Construction of a Prognostic Model.
Salah S; Lee JL; Rozzi A; Kitamura H; Matsumoto K; Srinivas S; Morales-Barrera R; Carles J; Al-Wardat R; Al-Rabi K; Maakoseh M
Clin Genitourin Cancer; 2016 Jun; 14(3):255-60. PubMed ID: 26552764
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of nutritional indices and body composition parameters including sarcopenia in patients treated with radiotherapy for urothelial carcinoma of the bladder.
Stangl-Kremser J; D'Andrea D; Vartolomei M; Abufaraj M; Goldner G; Baltzer P; Shariat SF; Tamandl D
Urol Oncol; 2019 Jun; 37(6):372-379. PubMed ID: 30578161
[TBL] [Abstract][Full Text] [Related]
15. Sarcopenia is a predictive factor for intestinal resection in admitted patients with Crohn's disease.
Bamba S; Sasaki M; Takaoka A; Takahashi K; Imaeda H; Nishida A; Inatomi O; Sugimoto M; Andoh A
PLoS One; 2017; 12(6):e0180036. PubMed ID: 28644887
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia Impairs Prognosis of Patients with Hepatocellular Carcinoma: The Role of Liver Functional Reserve and Tumor-Related Factors in Loss of Skeletal Muscle Volume.
Imai K; Takai K; Watanabe S; Hanai T; Suetsugu A; Shiraki M; Shimizu M
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28937616
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of the skeletal muscle index and systemic inflammatory index in patients with lymph node-positive breast cancer after radical mastectomy.
Tang R; Deng JP; Zhang L; Zhang WW; Sun JY; Chi F; Zhang J; Wu SG; He ZY
BMC Cancer; 2022 Mar; 22(1):234. PubMed ID: 35241010
[TBL] [Abstract][Full Text] [Related]
18. Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer.
Mayr R; Gierth M; Zeman F; Reiffen M; Seeger P; Wezel F; Pycha A; Comploj E; Bonatti M; Ritter M; van Rhijn BWG; Burger M; Bolenz C; Fritsche HM; Martini T
J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):505-513. PubMed ID: 29479839
[TBL] [Abstract][Full Text] [Related]
19. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
[TBL] [Abstract][Full Text] [Related]
20. Optimal Cutoff Values of Skeletal Muscle Index to Define Sarcopenia for Prediction of Survival in Patients with Advanced Gastric Cancer.
Nishigori T; Tsunoda S; Obama K; Hisamori S; Hashimoto K; Itatani Y; Okada K; Sakai Y
Ann Surg Oncol; 2018 Nov; 25(12):3596-3603. PubMed ID: 30167910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
